{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:36:40Z","timestamp":1792798600879,"version":"4.5.0"},"reference-count":129,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Fonds Monique Gaumond of the Universit\u00e9 de Montr\u00e9al","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"https:\/\/ror.org\/0161xgx34","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Bank of Canada","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"https:\/\/ror.org\/04eh5he50","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,4]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid antidepressant effects and has shown promise in reducing alcohol use, and acceptance and commitment therapy (ACT) can be effective for both substance use and mood disorders. This study explores the feasibility and acceptability of combining ACT with ketamine within the framework of the Montreal Model\u2014a structured, integrative psychedelic ketamine therapy developed for severe TRD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This study is a single-group, open-label feasibility trial at the Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM) Neuromodulation Ketamine Clinic in Montreal, Canada. 30 participants diagnosed with both alcohol use disorder and treatment-resistant depression will receive eight\u2009weekly in-person or virtual ACT sessions in addition to six intravenous ketamine infusions. The primary outcome is feasibility, assessed through study completion and protocol adherence. Secondary outcomes include recruitment rate, tolerability, safety, data completeness and healthcare resource use. Exploratory measures will examine changes in depressive symptoms, alcohol use and quality of life using validated tools. A subset of participants will participate in semistructured qualitative interviews to explore their experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was approved by the ethics committee of the CHUM on 14 May 2025. The results of the trial, including primary and secondary outcomes, will be published in peer-reviewed scientific journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06620276\">NCT06620276<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116969","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:56:08Z","timestamp":1773870968000},"page":"e116969","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06620276","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2787-2792","authenticated-orcid":false,"given":"Christina","family":"McAnulty","sequence":"first","affiliation":[{"name":"Research Centre, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychiatry and Addictology, Universit\u00e9 de Montr\u00e9al, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8439-5164","authenticated-orcid":false,"given":"Philippe","family":"Lavoie","sequence":"additional","affiliation":[{"name":"Research Centre, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychology, Concordia University, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Cyr","sequence":"additional","affiliation":[{"name":"Research Centre, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lavin","sequence":"additional","affiliation":[{"name":"Research Centre, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Elkrief","sequence":"additional","affiliation":[{"name":"Research Centre, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychiatry and Addictology, Universit\u00e9 de Montr\u00e9al, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Richard-Devantoy","sequence":"additional","affiliation":[{"name":"McGill Group for Suicide Studies, McGill University & Douglas Mental Health Research Institute, Montreal, Qu\u00e9bec, Canada"},{"name":"CISSS des Laurentides, Saint-J\u00e9r\u00f4me, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Rizkallah","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Quatuor MD, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lesp\u00e9rance","sequence":"additional","affiliation":[{"name":"Research Centre, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychiatry and Addictology, Universit\u00e9 de Montr\u00e9al, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gamin","sequence":"additional","affiliation":[{"name":"Research Centre, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychology, Universit\u00e9 de Sherbooke, Sherbrooke, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lembke","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Addictology, Universit\u00e9 de Montr\u00e9al, Montreal, Qu\u00e9bec, Canada"},{"name":"Centre de recherche, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Greenway","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychiatry, McGill University, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Garel","sequence":"additional","affiliation":[{"name":"Research Centre, Centre Hospitalier de l\u2019Universite de Montreal, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychiatry and Addictology, Universit\u00e9 de Montr\u00e9al, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2026031814553740000_16.3.e116969.1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"2026031814553740000_16.3.e116969.2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"2026031814553740000_16.3.e116969.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101135","article-title":"Bipolar disorders: an update on critical aspects","volume":"48","author":"Oliva","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"2026031814553740000_16.3.e116969.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.01.141"},{"key":"2026031814553740000_16.3.e116969.5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15295","article-title":"Longitudinal Interplay Between Alcohol Use, Mood, and Functioning in Bipolar Spectrum Disorders","volume":"7","author":"Sperry","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026031814553740000_16.3.e116969.6","doi-asserted-by":"crossref","unstructured":"Zhdanava M , Pilon D , Ghelerter I , et al . The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States. J Clin Psychiatry 2021;82. doi:10.4088\/JCP.20m13699","DOI":"10.4088\/JCP.20m13699"},{"key":"2026031814553740000_16.3.e116969.7","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32833c4ceb"},{"key":"2026031814553740000_16.3.e116969.8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20060864"},{"key":"2026031814553740000_16.3.e116969.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.07.045"},{"key":"2026031814553740000_16.3.e116969.10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jad.2021.12.090","article-title":"Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study","volume":"300","author":"Rathod","year":"2022","journal-title":"J Affect Disord"},{"key":"2026031814553740000_16.3.e116969.11","doi-asserted-by":"publisher","DOI":"10.1007\/s12199-008-0037-x"},{"key":"2026031814553740000_16.3.e116969.12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cpr.2012.12.003","article-title":"Couple and family involvement in adult mental health treatment: a systematic review","volume":"33","author":"Meis","year":"2013","journal-title":"Clin Psychol Rev"},{"key":"2026031814553740000_16.3.e116969.13","doi-asserted-by":"publisher","DOI":"10.1037\/ccp0000447"},{"key":"2026031814553740000_16.3.e116969.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.11406"},{"key":"2026031814553740000_16.3.e116969.15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(19)31775-1","article-title":"Alcohol use disorders","volume":"394","author":"Carvalho","year":"2019","journal-title":"The Lancet"},{"key":"2026031814553740000_16.3.e116969.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19761"},{"key":"2026031814553740000_16.3.e116969.17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-031323-115847"},{"key":"2026031814553740000_16.3.e116969.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3628"},{"key":"2026031814553740000_16.3.e116969.19","article-title":"Trajectories of Acute Antidepressant Efficacy: How Long to Wait for Response? A Systematic Review and Meta-Analysis of Long-Term, Placebo-Controlled Acute Treatment Trials","volume":"79","author":"Henssler","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"2026031814553740000_16.3.e116969.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.03.027"},{"key":"2026031814553740000_16.3.e116969.21","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1017\/S0033291722001246","article-title":"Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis","volume":"52","author":"Yan","year":"2022","journal-title":"Psychol Med"},{"key":"2026031814553740000_16.3.e116969.22","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.2\/dionescu"},{"key":"2026031814553740000_16.3.e116969.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.03.073"},{"key":"2026031814553740000_16.3.e116969.24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psc.2018.04.001","article-title":"Electroconvulsive Therapy in Depression: Current Practice and Future Direction","volume":"41","author":"Hermida","year":"2018","journal-title":"Psychiatr Clin North Am"},{"key":"2026031814553740000_16.3.e116969.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2034954"},{"key":"2026031814553740000_16.3.e116969.26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamapsychiatry.2017.1670","article-title":"Modern Electroconvulsive Therapy: Vastly Improved yet Greatly Underused","volume":"74","author":"Sackeim","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2026031814553740000_16.3.e116969.27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1176\/appi.ps.202000387","article-title":"Barriers to the Implementation of Electroconvulsive Therapy (ECT): Results From a Nationwide Survey of ECT Practitioners","volume":"72","author":"Wilkinson","year":"2021","journal-title":"PS"},{"key":"2026031814553740000_16.3.e116969.28","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20230524-02"},{"key":"2026031814553740000_16.3.e116969.29","article-title":"Treatment of Depression With Alcohol and Substance Dependence: A Systematic Review","volume":"12","author":"Alsheikh","year":"2020","journal-title":"Cureus"},{"key":"2026031814553740000_16.3.e116969.30","doi-asserted-by":"publisher","DOI":"10.1111\/add.14866"},{"key":"2026031814553740000_16.3.e116969.31","doi-asserted-by":"crossref","unstructured":"Stubbs KR , Van Bezooyen J , Tang Y . Chapter 31 - managing treatment-resistant depression with comorbid substance use disorders. In: Quevedo J , Riva-Posse P , Bobo WV , eds. Managing treatment-resistant depression. Academic Press, 2022: 461\u201372.","DOI":"10.1016\/B978-0-12-824067-0.00031-1"},{"key":"2026031814553740000_16.3.e116969.32","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.08060852"},{"key":"2026031814553740000_16.3.e116969.33","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12802"},{"key":"2026031814553740000_16.3.e116969.34","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.231015"},{"key":"2026031814553740000_16.3.e116969.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2000.tb04648.x"},{"key":"2026031814553740000_16.3.e116969.36","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5663274","article-title":"The Effects of Citalopram and Thalamic Dopamine D2\/3 Receptor Availability on Decision-Making and Loss Aversion in Alcohol Dependence","volume":"2022","author":"Zorick","year":"2022","journal-title":"Psychiatry J"},{"key":"2026031814553740000_16.3.e116969.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.04.037"},{"key":"2026031814553740000_16.3.e116969.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302399"},{"key":"2026031814553740000_16.3.e116969.39","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026031814553740000_16.3.e116969.40","doi-asserted-by":"publisher","DOI":"10.1177\/07067437241245384"},{"key":"2026031814553740000_16.3.e116969.41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13162-w","article-title":"Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories","volume":"10","author":"Das","year":"2019","journal-title":"Nat Commun"},{"key":"2026031814553740000_16.3.e116969.42","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19070684"},{"key":"2026031814553740000_16.3.e116969.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109606"},{"key":"2026031814553740000_16.3.e116969.44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0269881120970879","article-title":"Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial","volume":"35","author":"Rothberg","year":"2021","journal-title":"J Psychopharmacol"},{"key":"2026031814553740000_16.3.e116969.45","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.21030277"},{"key":"2026031814553740000_16.3.e116969.46","article-title":"Ketamine Can Reduce Harmful Drinking by Pharmacologically Rewriting Drinking Memories","volume":"87","author":"Das","year":"2020","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2026031814553740000_16.3.e116969.47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/02698811241254834","article-title":"Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems","volume":"38","author":"Gent","year":"2024","journal-title":"J Psychopharmacol"},{"key":"2026031814553740000_16.3.e116969.48","doi-asserted-by":"crossref","first-page":"209705","DOI":"10.1016\/j.josat.2025.209705","article-title":"Role of ketamine in the treatment of substance use disorders: A systematic review","volume":"175","author":"Janssen-Aguilar","year":"2025","journal-title":"J Subst Use Addict Treat"},{"key":"2026031814553740000_16.3.e116969.49","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41386-023-01689-y","article-title":"Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report","volume":"48","author":"Garel","year":"2023","journal-title":"Neuropsychopharmacol"},{"key":"2026031814553740000_16.3.e116969.50","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2026.10157","article-title":"Is the antidepressant efficacy of ketamine and esketamine mediated via opioid mechanisms?","volume":"69","author":"Lu","year":"2026","journal-title":"Eur Psychiatry"},{"key":"2026031814553740000_16.3.e116969.51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/17512433.2025.2459377","article-title":"The ketamine chameleon: history, pharmacology, and the contested value of experience","volume":"18","author":"Diep","year":"2025","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2026031814553740000_16.3.e116969.52","article-title":"Ketamine Treatment for Alcohol Use Disorder: A Systematic Review","volume":"15","author":"Kelson","year":"2023","journal-title":"Cureus"},{"key":"2026031814553740000_16.3.e116969.53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S2215-0366(22)00317-0","article-title":"Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability","volume":"9","author":"Smith-Apeldoorn","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"2026031814553740000_16.3.e116969.54","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1268832","article-title":"The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression","volume":"14","author":"Garel","year":"2023","journal-title":"Front Psychiatry"},{"key":"2026031814553740000_16.3.e116969.55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/09540261.2018.1474088","article-title":"Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy","volume":"30","author":"Walsh","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"2026031814553740000_16.3.e116969.56","doi-asserted-by":"crossref","unstructured":"Sloshower J . Integrating psychedelic medicines and psychiatry: theory and methods of a model clinic. In: Labate BC , Cavnar C , eds. Plant medicines, healing and psychedelic science: cultural perspectives. Cham: Springer International Publishing, 2018: 113\u201332.","DOI":"10.1007\/978-3-319-76720-8_7"},{"key":"2026031814553740000_16.3.e116969.57","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00005","article-title":"Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance","volume":"11","author":"Wolff","year":"2020","journal-title":"Front Psychiatry"},{"key":"2026031814553740000_16.3.e116969.58","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.868103","article-title":"Toward Synergies of Ketamine and Psychotherapy","volume":"13","author":"Mathai","year":"2022","journal-title":"Front Psychol"},{"key":"2026031814553740000_16.3.e116969.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2017.08.009"},{"key":"2026031814553740000_16.3.e116969.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.08.004"},{"key":"2026031814553740000_16.3.e116969.61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.14740\/jocmr4311","article-title":"The Use of Acceptance and Commitment Therapy in Substance Use Disorders: A Review of Literature","volume":"12","author":"Osaji","year":"2020","journal-title":"J Clin Med Res"},{"key":"2026031814553740000_16.3.e116969.62","doi-asserted-by":"crossref","DOI":"10.1093\/alcalc\/agae042","article-title":"Advancing research: a commentary on the untapped potential of acceptance and commitment therapy in alcohol use disorder treatment","volume":"59","author":"Garel","year":"2024","journal-title":"Alcohol Alcohol"},{"key":"2026031814553740000_16.3.e116969.63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcbs.2019.11.002","article-title":"Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame","volume":"15","author":"Sloshower","year":"2020","journal-title":"J Contextual Behav Sci"},{"key":"2026031814553740000_16.3.e116969.64","doi-asserted-by":"crossref","unstructured":"Greenway KT , Garel N , Dinh-Williams L-AL , et al . The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression. Br J Psychiatry 2025;1\u20139. doi:10.1192\/bjp.2025.102","DOI":"10.1192\/bjp.2025.102"},{"key":"2026031814553740000_16.3.e116969.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2005.06.006"},{"key":"2026031814553740000_16.3.e116969.66","doi-asserted-by":"publisher","DOI":"10.1111\/add.16052"},{"key":"2026031814553740000_16.3.e116969.67","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-024-06045-y","article-title":"Targeting emotion dysregulation in depression: an intervention mapping protocol augmented by participatory action research","volume":"24","author":"Lee","year":"2024","journal-title":"BMC Psychiatry"},{"key":"2026031814553740000_16.3.e116969.68","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-15-264","article-title":"Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study","volume":"15","author":"Teare","year":"2014","journal-title":"Trials"},{"key":"2026031814553740000_16.3.e116969.69","doi-asserted-by":"publisher","DOI":"10.1177\/0962280215588241"},{"key":"2026031814553740000_16.3.e116969.70","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40814-023-01416-w","article-title":"A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020","volume":"9","author":"Totton","year":"2023","journal-title":"Pilot Feasibility Stud"},{"key":"2026031814553740000_16.3.e116969.71","doi-asserted-by":"publisher","DOI":"10.1097\/mlr.0000000000001664"},{"key":"2026031814553740000_16.3.e116969.72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jad.2024.05.070","article-title":"Amount and frequency of psychotherapy as predictors of treatment outcome for adult depression: A meta-regression analysis","volume":"359","author":"Ciharova","year":"2024","journal-title":"J Affect Disord"},{"key":"2026031814553740000_16.3.e116969.73","unstructured":"Rizkallah E , Pr\u00e9vost M-J , Garel N . Therapist\u2019s manual: an evolving, patient-adapted acceptance and commitment therapy. 2025."},{"key":"2026031814553740000_16.3.e116969.74","unstructured":"Rizkallah E , Pr\u00e9vost M-J , Garel N . Therapy booklet: an evolving, patient-adapted acceptance and commitment therapy. 2025."},{"key":"2026031814553740000_16.3.e116969.75","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.54719","article-title":"Music as an Intervention to Improve the Hemodynamic Response of Ketamine in Depression: A Randomized Clinical Trial","volume":"7","author":"Greenway","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026031814553740000_16.3.e116969.76","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"2026031814553740000_16.3.e116969.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2010.08.013"},{"key":"2026031814553740000_16.3.e116969.78","doi-asserted-by":"crossref","unstructured":"Sobell LC , Sobell MB . Timeline follow-back. In: Litten RZ , Allen JP , eds. Measuring alcohol consumption: psychosocial and biochemical methods. Totowa, NJ: Humana Press, 1992: 41\u201372.","DOI":"10.1007\/978-1-4612-0357-5_3"},{"key":"2026031814553740000_16.3.e116969.79","first-page":"11782218231157558","article-title":"A Systematic Approach to Standardizing Drinking Outcomes From Timeline Followback Data","volume":"17","author":"Marini","year":"2023","journal-title":"Subst Abuse"},{"key":"2026031814553740000_16.3.e116969.80","unstructured":"World Health Organization . International guide for monitoring alcohol consumption and related harm. Switzerland: Geneva: Department of Mental Health and Substance Dependence, Noncommunicable Diseases and Mental Health Cluster, World Health Organization, 2000."},{"key":"2026031814553740000_16.3.e116969.81","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2018.1456545"},{"key":"2026031814553740000_16.3.e116969.82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1997.tb03811.x"},{"key":"2026031814553740000_16.3.e116969.83","doi-asserted-by":"crossref","unstructured":"Singleton EG , Tiffany ST , Henningfield JE . Alcohol craving questionnaire-NOW. 1995.","DOI":"10.1037\/t01505-000"},{"key":"2026031814553740000_16.3.e116969.84","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-47148-5_8"},{"key":"2026031814553740000_16.3.e116969.85","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000210043","article-title":"Alcohol craving scale based on three factors","volume":"15","author":"Jimenez","year":"2009","journal-title":"Eur Addict Res"},{"key":"2026031814553740000_16.3.e116969.86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2009.03.019","article-title":"Evaluation of the Alcohol Craving Questionnaire-Now factor structures: application of a cue reactivity paradigm","volume":"103","author":"Connolly","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"2026031814553740000_16.3.e116969.87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1995.tb01475.x"},{"key":"2026031814553740000_16.3.e116969.88","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830030047008"},{"key":"2026031814553740000_16.3.e116969.89","doi-asserted-by":"publisher","DOI":"10.1037\/\/0893-164X.10.2.81"},{"key":"2026031814553740000_16.3.e116969.90","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1994.55.141"},{"key":"2026031814553740000_16.3.e116969.91","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/1533256X.2011.593445","article-title":"Development of a Brief Abstinence Self-Efficacy Measure","volume":"11","author":"McKiernan","year":"2011","journal-title":"J Soc Work Pract Addict"},{"key":"2026031814553740000_16.3.e116969.92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1986.tb02723.x"},{"key":"2026031814553740000_16.3.e116969.93","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"2026031814553740000_16.3.e116969.94","doi-asserted-by":"crossref","unstructured":"Wikberg C , Nejati S , Larsson MEH , et al . Comparison Between the Montgomery-Asberg Depression Rating Scale-Self and the Beck Depression Inventory II in Primary Care. Prim Care Companion CNS Disord 2015;17. doi:10.4088\/PCC.14m01758","DOI":"10.4088\/PCC.14m01758"},{"key":"2026031814553740000_16.3.e116969.95","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1060028019892644","article-title":"Esketamine: A Novel Option for Treatment-Resistant Depression","volume":"54","author":"Bozymski","year":"2020","journal-title":"Ann Pharmacother"},{"key":"2026031814553740000_16.3.e116969.96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.09.043"},{"key":"2026031814553740000_16.3.e116969.97","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852924002451","article-title":"Esketamine nasal spray versus quetiapine XR in adults with treatment-resistant depression: a secondary analysis of the ESCAPE-TRD randomized clinical trial","volume":"30","author":"McIntyre","year":"2025","journal-title":"CNS Spectr"},{"key":"2026031814553740000_16.3.e116969.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.10.018"},{"key":"2026031814553740000_16.3.e116969.99","doi-asserted-by":"publisher","DOI":"10.1207\/s15327752jpa6703_13"},{"key":"2026031814553740000_16.3.e116969.100","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.47.2.343"},{"key":"2026031814553740000_16.3.e116969.101","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"2026031814553740000_16.3.e116969.102","unstructured":"Pahnke WN . Drugs and mysticism: an analysis of the relationship between psychedelic drugs and the mystical consciousness: a thesis. 1963"},{"key":"2026031814553740000_16.3.e116969.103","first-page":"149","article-title":"Psychedelic drugs and mystical experience","volume":"5","author":"Pahnke","year":"1969","journal-title":"Int Psychiatry Clin"},{"key":"2026031814553740000_16.3.e116969.104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-5906.2012.01685.x"},{"key":"2026031814553740000_16.3.e116969.105","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855974"},{"key":"2026031814553740000_16.3.e116969.106","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10862-019-09776-5","article-title":"Evaluation of the Psychometric Properties of the Five Facet of Mindfulness Questionnaire","volume":"42","author":"Shallcross","year":"2020","journal-title":"J Psychopathol Behav Assess"},{"key":"2026031814553740000_16.3.e116969.107","unstructured":"APA dictionary of psychology. Available: https:\/\/dictionary.apa.org\/ [Accessed 8 Oct 2025]."},{"key":"2026031814553740000_16.3.e116969.108","doi-asserted-by":"publisher","DOI":"10.1037\/\/0022-3514.59.1.91"},{"key":"2026031814553740000_16.3.e116969.109","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0898010107307456","article-title":"Absorption: an individual difference to consider in mind-body interventions","volume":"26","author":"Menzies","year":"2008","journal-title":"J Holist Nurs Off J Am Holist Nurses Assoc"},{"key":"2026031814553740000_16.3.e116969.110","doi-asserted-by":"crossref","first-page":"103793","DOI":"10.1016\/j.actpsy.2022.103793","article-title":"Absorption and dissociation mediate the relationship between direct verbal suggestibility and impulsivity\/compulsivity","volume":"231","author":"Acunzo","year":"2022","journal-title":"Acta Psychol (Amst)"},{"key":"2026031814553740000_16.3.e116969.111","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1037\/0033-3204.43.3.271","article-title":"The working alliance: Where are we and where should we go?","volume":"43","author":"Castonguay","year":"2006","journal-title":"Psychotherapy (Chic)"},{"key":"2026031814553740000_16.3.e116969.112","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.945294","article-title":"The Working Alliance Inventory\u2019s Measurement Properties: A Systematic Review","volume":"13","author":"Paap","year":"2022","journal-title":"Front Psychol"},{"key":"2026031814553740000_16.3.e116969.113","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/09638237.2021.1875422","article-title":"Psychometric properties of the EQ-5D-5L in patients with major depression: factor analysis and Rasch analysis","volume":"31","author":"Bilbao","year":"2022","journal-title":"J Ment Health"},{"key":"2026031814553740000_16.3.e116969.114","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.09.067231"},{"key":"2026031814553740000_16.3.e116969.115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/mpr.1523","article-title":"Psychometric properties and a latent class analysis of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in a pooled dataset of community samples","volume":"25","author":"MacLeod","year":"2016","journal-title":"Int J Methods Psychiatr Res"},{"key":"2026031814553740000_16.3.e116969.116","doi-asserted-by":"publisher","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G"},{"key":"2026031814553740000_16.3.e116969.117","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.695335","article-title":"\u201cThis Is Something That Changed My Life\u201d: A Qualitative Study of Patients\u2019 Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders","volume":"12","author":"Mollaahmetoglu","year":"2021","journal-title":"Front Psychiatry"},{"key":"2026031814553740000_16.3.e116969.118","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2026031814553740000_16.3.e116969.119","doi-asserted-by":"crossref","unstructured":"Joffe H . Thematic analysis. In: Qualitative research methods in mental health and psychotherapy. John Wiley & Sons Ltd, 2011: 209\u201323.","DOI":"10.1002\/9781119973249.ch15"},{"key":"2026031814553740000_16.3.e116969.120","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"2026031814553740000_16.3.e116969.121","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.081229"},{"key":"2026031814553740000_16.3.e116969.122","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14344.1","article-title":"Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide","volume":"7","author":"Duman","year":"2018","journal-title":"F1000Res"},{"key":"2026031814553740000_16.3.e116969.123","doi-asserted-by":"crossref","first-page":"887255","DOI":"10.3389\/fpsyg.2022.887255","article-title":"Psychedelic-Assisted Psychotherapy\u2014A Systematic Review of Associated Psychological Interventions","volume":"13","author":"Cavarra","year":"2022","journal-title":"Front Psychol"},{"key":"2026031814553740000_16.3.e116969.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2021.08.003"},{"key":"2026031814553740000_16.3.e116969.125","doi-asserted-by":"crossref","first-page":"100316","DOI":"10.1016\/j.bpsgos.2024.100316","article-title":"Experiences of Awe Mediate Ketamine\u2019s Antidepressant Effects: Findings From a Randomized Controlled Trial in Treatment-Resistant Depression","volume":"4","author":"Aepfelbacher","year":"2024","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"2026031814553740000_16.3.e116969.126","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.03.011"},{"key":"2026031814553740000_16.3.e116969.127","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716659417"},{"key":"2026031814553740000_16.3.e116969.128","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609"},{"key":"2026031814553740000_16.3.e116969.129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S2215-0366(17)30130-X","article-title":"Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population","volume":"4","author":"Hasin","year":"2017","journal-title":"Lancet Psychiatry"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:56:20Z","timestamp":1773870980000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":129,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,18]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2026-116969"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116969","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}